Cargando…
Correction for: Bacopaside I ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid
Autores principales: | Li, Yuanyuan, Yuan, Xing, Shen, Yunheng, Zhao, Jing, Yue, Rongcai, Liu, Fang, He, Weiwei, Wang, Rui, Shan, Lei, Zhang, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008494/ https://www.ncbi.nlm.nih.gov/pubmed/36849256 http://dx.doi.org/10.18632/aging.204531 |
Ejemplares similares
-
Bacopaside I ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid
por: Li, Yuanyuan, et al.
Publicado: (2016) -
Erratum: Bacopaside I ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid
por: Li, Yuanyuan, et al.
Publicado: (2016) -
Correction: Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice
por: Cai, Haobin, et al.
Publicado: (2018) -
Intraperitoneal injection of IFN-γ restores microglial autophagy, promotes amyloid-β clearance and improves cognition in APP/PS1 mice
por: He, Zitian, et al.
Publicado: (2020) -
Klotho overexpression improves amyloid‐β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease
por: Zhao, Yue, et al.
Publicado: (2020)